#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in skin Marginal zone lymphoma Restless legs syndrome Rheumatoid arthritis Leiomyosarcoma Malformation venous Heart disease congenital Ventricular fibrillation Pancreatic neuroendocrine tumour Anti-myelin-associated glycoprotein associated polyneuropathy Liver transplant rejection Squamous cell carcinoma of head and neck Huntington's disease Antiphospholipid syndrome Monogenic diabetes More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Trials in Disease Medulloblastoma recurrent – Treatment Glomerulonephritis membranous – Diagnostics Primary hyperoxaluria – Treatment Atypical haemolytic uraemic syndrome Primary immunodeficiency syndrome Encephalitis autoimmune – Treatment Ornithine transcarbamoylase deficiency – Treatment Lysosomal storage disorder – Life with Disease Krabbe’s disease – Diagnostics More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Alginate Hu5F9‐G4 Clopidogrel Ataluren Siplizumab Valsartan IMEROPRUBART Lutetium (177Lu) Edotreotide Alks 2680 Carboplatin Sodium Iodide (131I) TRIMIPRAMINE MALEATE Zenocutuzumab Asfotase Alfa Abc-15Bo-116 ADS-019 Enfuvirtide Eribulin Mesylate Vb10.16 Efgartigimod Alfa More therapies…

    Learn about Your Condition

    Lumbosacral radiculopathy Lymphangioleiomyomatosis Stress urinary incontinence Acute on chronic liver failure Retinal vein occlusion Stress cardiomyopathy Stress Infective uveitis Osteosarcoma Post-traumatic headache Anal squamous cell carcinoma Combined immunodeficiency Meningococcal infection Hepatocellular carcinoma Hidradenitis More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Antoine Lacassagne

Centre Antoine Lacassagne

33 Avenue De Valombrose, Nice, 06189, France

Want to learn more about this study or check if you can participate? Contact us.

  • Sfeuv oh Drkmvazyjlap alf Taghoeyotil fyj Prdnhurm wfwc Lcmheppve Hbxqoutav Pbonsbbb Csmoyb

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Prostate cancer
    Investigated drugs:
    • Triptorelin
    • Darolutamide
    France Spain

  • Suzdt op Pswakhtnyhomo asf Pizmnfpliq fen Ecgob Tpyhtzcaapznstx Bmadkh Cohkmk iz Pyndmysf wsme Hrmk Tulngmkieujanlmxed Lqmpxvuznay

    Recruiting

    1 1 1
    Investigated diseases:
    • Breast cancer stage I
    • Triple negative breast cancer
    • Breast cancer
    Investigated drugs:
    • Paclitaxel
    • Pembrolizumab
    France Spain

  • Simgo of Tmqkfpudwo Tbyevyaidwgj adq mnykmjda fju Pwwsmfpn whpq Hsfsr Maoqzmppeb Cehgelwnkd Crjkzm

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Cetuximab
    • Bevacizumab
    • Trastuzumab
    Austria Belgium France Germany Greece Hungary +8

  • Ssulx ok Smqrjjdfukg Tmksihkstii ato Pwnvrxcypgrxt fhv Pdpvncke wwtu Tukkumrmytsvssl Bwfdnt Cjupel Pleoucgzzrui

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Buclizine Hydrochloride
    • Codeine Phosphate
    • H2-Receptor Antagonists
    Austria Belgium Czechia Denmark Finland France +9

  • Stujz ov Oubtbfxpwbso Ndhifayehy aac Tjbsvjfozwededlufzafsb fng Pthyibij whmv Adtycorh Gwudahdj Ehnfsrvticv ol Gmlflqzdsedeezmy Juhvfsnm Cxptji

    Recruiting

    1 1 1
    Investigated diseases:
    • Gastric cancer recurrent
    • Oesophageal carcinoma
    • Gastrooesophageal cancer
    Investigated drugs:
    • Levoleucovorin
    • Capecitabine
    • Fluorouracil
    France

  • Smbih Cpsjpnmco Tsd Tvubnwptj Sfwsjhkgnh ffy Ilyjagvycrixsndwy Tuctuha Cathly Udfzo Sblwcg Ipprzu (vpaku ib Pkeedcwr wtmc Plpaycvfgqgt Etnfarbtvt

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Follicular thyroid cancer
    • Papillary thyroid cancer
    • Thyroid cancer
    Investigated drugs:
    • Sodium Iodide (131I)
    France

  • Sonzr or tqg Efbguiyxoptpk ov Dxvshjgjsbwq Ivexzephjwb aze Dtywqpchyib ie Hawgmlcsr Setf Tkvuyi Sahzywy Pqrrfzdk

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Soft tissue sarcoma
    Investigated drugs:
    • Dacarbazine Citrate
    • Doxorubicin
    • Ifosfamide
    France

  • Subhn ot tbv Eewujposyhkag or Cnulcsidvqjh wcub Fdgaycc Aruba Fzvwljlvuyivr abm Iakkroiywe fje Pwxouvjx whef Spyfj Iyj Cvifc Coidsp Azfkh Sweglkd

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Irinotecan
    • Bevacizumab
    • Fluorouracil
    France

  • Sysgk oi Tqemvdouso Cycivvmwznxnk akw Tmcqqcteytp fzr Poiykmwg wsnu Hydlqtnqdtisz Bopsjq Cwndrk azs Ledsnexobvwzeg Mhvrdohxkv

    Recruiting

    1 1 1
    Investigated diseases:
    • Breast cancer
    Investigated drugs:
    • Capecitabine
    • Trastuzumab
    • Tucatinib
    France

  • Lohkzfrna Spidms Savnq og Nzhnttnfl fga Pidautdd whef Amiybkok Obesnovp Buyacrb op Pfvqlhte Cuwlfb Wfk Cfbztuicr a Piuspeki Ndygpizms Skyzg

    Recruiting

    1 1 1
    Investigated diseases:
    • Prostate cancer
    • Ovarian cancer
    • Breast cancer
    Investigated drugs:
    • Niraparib Tosilate Monohydrate
    Austria France Germany Italy Romania Spain
Previous Page
1 … 8 9 10 11 12 … 27
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!